IQVIA · 1 month ago
Site Research Assistant - Southfield, MI
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. We are seeking a detail-oriented Research Assistant to support clinical trial activities in compliance with all applicable regulations.
AnalyticsHealth CareLife Science
Responsibilities
EDC entry and query resolution
Maintain regulatory binder and ensure compliance with documentation standards
Schedule and coordinate subject visits and procedures
Develop strong working relationships and maintain effective communication with study team members
Build trust and respect with investigators and office staff
Assist with screening, recruiting, and enrolling research subjects
Perform patient/research participant scheduling and collect history
Coordinate follow-up care and laboratory procedures
Adhere to IRB-approved protocols and assist in informed consent processes
Support the safety of research subjects
Comply with company and Sponsor policies, SOPs, and guidelines
Qualification
Required
Minimum of an associate's degree or equivalent education and experience
At least 1 year of experience in a clinical research setting preferred
Working knowledge of clinical trials and Good Clinical Practices (GCP)
Familiarity with protocol-specific procedures, consent forms, and study schedules
Proficiency in EDC entry and query resolution
Experience in visit scheduling and regulatory binder upkeep
Strong attention to detail and ability to prioritize tasks
Excellent communication and relationship-building skills
Applicable certifications and licenses as required by company, state, or regulatory bodies
Preferred
At least 1 year of experience in a clinical research setting preferred
Benefits
Incentive plans
Bonuses
Health and welfare and/or other benefits
Company
IQVIA
IQVIA provides analytics, compliance, and management solutions to the life sciences industry.
Funding
Current Stage
Public CompanyTotal Funding
$3.5B2025-06-02Post Ipo Debt· $2B
2023-11-14Post Ipo Debt· $500M
2023-05-18Post Ipo Debt· $1B
Leadership Team
Recent News
Company data provided by crunchbase